Chris Cull completed his bike ride across Canada last week, aimed at raising awareness about the addictive potential of medication drugs. He ended his ride in St. John’s, Newfoundland and Labrador, at Quidi Vidi Gut. I had a chance to meet Chris and his team at my house.
Chris is producing a documentary aimed at advancing awareness of his cause, the dangers of opioid medications prescribed legally. His interest is fired by his own experience as a patient addicted to OxyContin, which brings me to our connection.
I am part of a group of class action law firms who represent plaintiffs in a proposed class action against Purdue Pharma, the manufacturer of OxyContin. By coincidence, we are filing our certification affidavit evidence, seeking a national class of persons addicted to prescribed OxyContin, this week.
I gave Chris an interview, talking about what I know about the history of OxyContin use, and the revelations which have come to light, in the United States and in Canada. OxyContin was first approved by the FDA in 1995, and by Health Canada in 1996. Purdue Pharma made close to $1 billion per year in sales during the heyday of OxyContin, until their marketing plans hit a major obstacle in the form of the U.S. Attorney for Eastern Virginia.
In a 2007 plea bargain, Purdue Pharma and its top executives pled guilty to criminal charges of misbranding, and fines were paid in the amount of $634 million. It was the revelations set out in the Agreed Statement of Facts which attracted interest from class action law firms in Canada like my own.
Preliminary issues have hung up the lawsuit since it was filed in 2009, but now we are ready to go and hope to have a date for argument of certification very soon. Certification is what determines whether you are a class action or not.
Anyone who has encountered addiction issues with legally prescribed OxyContin can register for the class action by contacting Patient Injury Law. We will see to it that your contact information is provided to the class action firms responsible for where you live.